P D Badman

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Metastatic Breast Cancer

Peritoneal Dialysis

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, Michael J Seckl
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 13 (1) (2022)